REGN 241227 820.00C (REGN241227C820000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

REGN241227C820000

Watchlist

0.25
0.000.00%

15min DelayClose Dec 27 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Kevin Travers16:21 ET
Wall Street Today: Labor Gains Hurt a Hurting Market
Kevin Travers16:08 ET
Forecasting The Future: 22 Analyst Projections For Regeneron Pharmaceuticals
Benzinga15:00 ET
4D Molecular, FDA Agree on Phase 3 Design for DME Candidate
Seeking Alpha11:18 ET
First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock
Kevin Travers11:16 ET
Regeneron Pharma Is Maintained at Overweight by Wells Fargo
Dow JonesJan 10 09:22 ET · Ratings

Comments

韭菜变主力

10 hours ago

$Regeneron Pharmaceuticals (REGN.US)$ It’s doing this kind of thing. Kind of scary. Nobody wants it for above 700.

韭菜变主力

Jan 7 23:51

$Regeneron Pharmaceuticals (REGN.US)$ This is in NDX and could benefit from the weakness of mega-cap tech stocks in the index.

韭菜变主力

Dec 31 16:47

$Regeneron Pharmaceuticals (REGN.US)$Nice. It’s quiet here and just broke the steep down trend.

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

10xStockPicks

Dec 14, 2024 21:19

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...